Nama's AI scorecard currently rates Accelerant Hold (5.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is ARX's P/E ratio?

Accelerant trades at a trailing price-to-earnings ratio of 17.9.

When does ARX report earnings?

Accelerant's next scheduled report is on Nov 11, 2026. Analysts expect EPS of $0.20.

What is the ARX price target?

The median analyst price target from 3 analysts is $20.25, with a range of $20.25 – $20.25.

Is ARX Shariah compliant?

Nama's AAOIFI-style screen reads Accelerant as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Nama Insights

Accelerant (ARX)

Financial Services · Insurance Brokers · NYSE

Accelerant (ARX) is a Financial Services company in the Insurance Brokers industry. It has a market capitalization of $4.32B, a trailing price-to-earnings ratio of 17.9 and a free-cash-flow yield of 10.7%. Over the most recent reported fiscal year, revenue grew 47.1% and free cash flow per share fell 38.8%. Nama's AI scorecard rates it Hold, 5.2 out of 10. On 12-month momentum it ranks in the rising band of its market.

AI scorecard

Hold · 5.2/10

The sections balance. As of Nov 7, 2026.

Momentum

Rising · +63.9% over 12 months ex. last

Second-best fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-36.2%

How far the last close sits under the highest price of the past five years.

Market cap	$4.32B
Trailing P/E	17.9
Price / book	6.0
Price / sales	4.0
FCF yield	10.7%
Dividend yield	—
Gross margin	65.1%
Operating margin	15.6%
Net margin	-127.5%
Revenue growth (YoY)	+47.1%
Revenue growth (3-yr annual)	+60.4%
EPS growth (YoY)	—
FCF/share growth (YoY)	-38.8%
Beta	—
Exchange	NYSE
Sector	Financial Services
Industry	Insurance Brokers

ARX earnings

Next report: Nov 11, 2026 (Q3 2026, EPS estimate $0.20). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q2 2026	Aug 13, 2026	$0.32	$0.16	+100.0%	$373.60M
Q1 2026	May 13, 2026	$0.17	$0.16	+6.2%	$279.10M
Q4 2025	Mar 18, 2026	$0.23	$0.22	+4.5%	$209.40M
Q3 2025	Nov 12, 2025	$0.39	$0.21	+85.7%	$280.70M

ARX analyst price target

Median target $20.25 from 3 analysts, ranging $20.25 – $20.25.

Insurance Brokers peers

Ticker	Company	Market cap	P/E
MRSH	Marsh & McLennan Companies	$97.39B	19.7
AJG	Arthur J. Gallagher	$72.21B	22.2
AON	Aon	$71.03B	18.1
WTW	Willis Towers Watson Public	$30.33B	17.5
BRO	Brown & Brown	$23.92B	16.2
ERIE	Erie Indemnity	$14.28B	21.6
BWIN	Baldwin Insurance Group	$4.50B	17.4
CRVL	CorVel	$4.20B	169.7

Explore live ARX data on Nama Insights →

ARX FAQ

Is ARX a buy?: Nama's AI scorecard currently rates Accelerant Hold (5.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is ARX's P/E ratio?: Accelerant trades at a trailing price-to-earnings ratio of 17.9.
When does ARX report earnings?: Accelerant's next scheduled report is on Nov 11, 2026. Analysts expect EPS of $0.20.
What is the ARX price target?: The median analyst price target from 3 analysts is $20.25, with a range of $20.25 – $20.25.
Is ARX Shariah compliant?: Nama's AAOIFI-style screen reads Accelerant as Not Shariah Compliant. At least one of the three ratios or the industry test failed.